Late treatment study
et al., Journal of Thrombosis and Thrombolysis, doi: 10.1007/s11239-020-02162-z (Peer Reviewed)
The association between treatment with heparin and survival in patients with Covid-19
2075 hospital patients in Spain. HC
Q reduces mortality from 30% to 13%. Not adjusted for age and gender. HC
Q group 10% more males and 6 years younger. Study primarily interested in Heparin.
Please send us corrections, updates, or comments.